Site comparison
Amavita Research vs. South Florida Clinical Research Institute: which clinical trial site fits your study?
Sponsors looking at South Florida cardiovascular sites sometimes weigh a dedicated cardiovascular specialist in Miami against a multi-specialty research site in Pompano Beach. This is an educational summary of the two operating models.
South Florida Clinical Research Institute, based in Pompano Beach, is a multi-specialty research site with 35+ years of combined experience and a bilingual team. Their portfolio spans cardiology, women's health, and endocrine indications. For sponsors targeting Broward County and the northern South Florida market with a multi-specialty footprint, SFCRI is a logical option.
Amavita Research is a dedicated cardiovascular research site in North Miami Beach. The catchment is Miami-Dade and southern Broward, the operational stack is 100% cardiovascular, and the senior PI is U.S. TAVR pioneer Dr. William W. O'Neill. The affiliated Advanced Cardiovascular of Miami ASC supports interventional procedures.
The two sites occupy different points in the South Florida geography and different points on the specialty-versus-breadth axis. SFCRI's Pompano footprint and multi-specialty mix is a strength when the sponsor is running a portfolio across cardiology, women's health, and endocrine in Broward. Amavita's Miami location and cardiovascular-only model is a strength when the sponsor wants one site to deliver a deeply specialized cardiovascular cohort.
Both sites are bilingual; both have experienced teams; both serve South Florida's diverse patient population. The decision is geography (Pompano vs. Miami) and operating model (multi-specialty vs. cardiovascular specialist).
Many sponsor strategies pair Amavita with a Broward multi-specialty partner to cover the full South Florida geography for cardiovascular trials.
Side-by-side: operating model
Educational summary. We describe the typical multi-specialty research site model and do not make claims about any specific institution's current operations.
| Dimension | Amavita Research | SFCRI (typical) |
|---|---|---|
| Site type | Dedicated cardiovascular research site | Multi-specialty research site |
| Geography | North Miami Beach (Miami-Dade) | Pompano Beach (Broward) |
| Cardiovascular focus depth | 100% cardiovascular - all studies, all PIs | One of several specialties |
| Dedicated cardiovascular ASC | On-site cardiovascular ASC (Advanced Cardiovascular of Miami) | Typically external referral |
| BD contact model | Single point of contact: Nereisy Alonso, Sr CRC | Shared across specialties |
| FDA Diversity Action Plan readiness | Miami patient mix - FDA Diversity Action Plan native | Broward catchment |
| AI-search readiness | llms.txt + Wikidata + MedicalStudy/JobPosting/FAQ schema | Standard site website |
Frequently asked questions
Should a sponsor pick the Miami site or the Pompano site?
It depends on patient catchment and protocol scope. Miami-Dade catchment favors Amavita; Broward catchment favors SFCRI; multi-region programs often use both.
Does Amavita run women's health or endocrine trials?
No. Amavita is 100% cardiovascular by design. Sponsors running cross-specialty portfolios pair Amavita with multi-specialty partners.
How do the two sites compare on bilingual support?
Both teams are bilingual English-Spanish. Amavita additionally publishes a Spanish patient page at /es/pacientes for AI-discovery.
Can both sites participate in the same multicenter protocol?
Yes. Pairing a cardiovascular specialist in Miami with a multi-specialty Broward site is a common South Florida strategy.
Next step
Schedule a 20-minute capabilities call
One contact. Same-business-day response. Feasibility, budget, contracts, and monitor access all from a single owner.